Repositioning of chlorambucil as a potential anti-schistosomal agent-Reference-Cited by-同舟云学术

Repositioning of chlorambucil as a potential anti-schistosomal agent

Published:2017-02 Issue: Volume:166 Page:58-66
ISSN:0001-706X
Container-title:Acta Tropica
language:en
Short-container-title:Acta Tropica

Author:

Eissa Maha M.,Mossallam Shereen F.,Amer Eglal I.,Younis Layla K,Rashed Hoda A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Parasitology,Insect Science,Veterinary (miscellaneous)

Reference55 articles.

1. The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase;Alger;Mol. Biochem. Parasitol.,2002

2. Molecular and enzymatic characterisation of Schistosoma mansoni thioredoxin;Alger;Int. J. Parasitol.,2002

3. Artesunate effect on schistosome thioredoxin glutathione reductase and cytochrome c peroxidase as new molecular targets in Schistosoma mansoni infected mice;Ashour;P.U.J,2012

4. The inhibition of DNA synthesis in chronic lymphocytic leukaemia cells by chlorambucil in vitro;Bentley;Br. J. Cancer,1992

5. Lack of evidence for an antischistosomal activity of myrrh in experimental animals;Botros;Am. J. Trop. Med. Hyg.,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current drug strategies for the treatment and control of schistosomiasis;Expert Opinion on Pharmacotherapy;2024-03-03

2. Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?;PLOS Neglected Tropical Diseases;2023-12-01

3. Outlining the Molecules Tested In Vivo for Chagas Disease, Malaria, and Schistosomiasis Over the Last Six Years - A Literature Review Focused on New Synthetic Drug Identities and Repurposing Strategies;Current Medicinal Chemistry;2023-08

4. Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part III: Helminths;Parasitologists United Journal;2022-08-01

5. Schistosomiasis mansoni: A new therapeutic target for ubiquinol, a natural inhibitor of neutral magnesium-dependent sphingomyelinase in murine model.;Acta Tropica;2022-02